Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aptus PharmaBOM:544529 +3.63%18 PB Ratio is 19.80 as of Jul. 31, 2026, which is 24% above its 10-year median of 16.02. GuruFocus rates BOM:544529 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 112 Medical Distribution companies, Aptus Pharma ranks worse than 98.21% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-31), Aptus Pharma's share price is ₹269.50. Aptus Pharma's Book Value per Share for the quarter that ended in Mar. 2026 was ₹13.61. Hence, Aptus Pharma's PB Ratio of today is 19.80.
The historical rank and industry rank for Aptus Pharma's PB Ratio or its related term are showing as below:
BOM:544529'
s PB Ratio Range Over the Past 10 Years
Min: 8.17 Med: 16.02 Max: 35.08
Current: 19.8
During the past 4 years, Aptus Pharma's highest PB Ratio was 35.08. The lowest was 8.17. And the median was 16.02.
BOM:544529's PB Ratio is ranked worse than 98.21% of 112
companies
in the Medical Distribution industry
Industry Median: 1
vs BOM:544529: 19.80
During the past 12 months, Aptus Pharma's average Book Value Per Share Growth Rate was 235.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 188.80% per year.
During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Aptus Pharma was 188.80% per year. The lowest was 188.80% per year. And the median was 188.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Aptus Pharma PB Ratio Related Terms
Aptus Pharma PB Ratio Historical Data
* Premium members only.
The historical data trend for Aptus Pharma's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Aptus Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aptus Pharma PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Aptus Pharma's PB Ratio distribution charts can be found below:
* The bar in red indicates where Aptus Pharma's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Aptus Pharma's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Aptus Pharma (BOM:544529) has a PB Ratio of 19.80 as of Jul. 31, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Aptus Pharma and its competitors. This is 24% above median its historical median of 16.02. Over the past decade, Aptus Pharma's PB Ratio has ranged from 8.17 to 35.08. According to the industry distribution chart, Aptus Pharma ranks #110 out of 112 companies in the Medical Distribution industry, placing it in the top 98.2%.
Is Aptus Pharma's PB Ratio too high?
Aptus Pharma's current PB Ratio of 19.80 is 24% above median its 10-year median of 16.02. Over the past 10 years, this metric has ranged from a low of 8.17 to a high of 35.08. The Medical Distribution industry median PB Ratio is 1.00. Aptus Pharma's value of 19.80 is 1880% above this industry median. Based on the distribution chart, Aptus Pharma ranks #110 out of 112 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Aptus Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Aptus Pharma's PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Aptus Pharma ranks #110 out of 112 companies for PB Ratio. This places Aptus Pharma in the lower half of its industry. The industry median PB Ratio is 1.00. Aptus Pharma's value of 19.80 is 1880% above this benchmark. Historically, Aptus Pharma's own PB Ratio has ranged from 8.17 to 35.08 over the past decade. While the company's 10-year median is 16.02 vs. the industry median of 1.00, Aptus Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.00, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aptus Pharma's current PB Ratio of 19.80 is 1880% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Aptus Pharma and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aptus Pharma's current PB Ratio is 19.80, which is 24% above median its own 10-year median of 16.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptus Pharma stock overvalued right now?
Aptus Pharma (BOM:544529) has a current PB Ratio of 19.80. The current PB Ratio is 19.80, which is 24% above median its 10-year median of 16.02 and 1880% above the Medical Distribution industry median of 1.00. Aptus Pharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Aptus Pharma (BOM:544529), the current PB Ratio is 19.80 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
18GF Score
Get the complete analysis for BOM:544529
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544529 has been successfully added to your 
